← Eichor
Study identifier: NCT05796531 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization

Condition: Self-Injurious Behavior · Suicidal Ideation · Suicide Attempts  ·  Sponsor: Franciscan Hospital For Children, INC.

PhaseNA
Planned participants155
Who can joinAll sexes, 12 Years to 19 Years
Healthy volunteersNo

About this study

Suicide is the 2nd leading cause of death among adolescents, with the highest risk period for suicide being the month following psychiatric inpatient hospitalization. The investigators propose testing a brief, scalable intervention using evaluative conditioning aimed at reducing suicidal thoughts and behaviors among adolescents during and after inpatient hospitalization. Scalable interventions, such as the one proposed that reduce suicide risk during this markedly high-risk period, could result in large-scale decreases in suicide death.

This description comes directly from the study's public registry record.

Talk to the study team

Kelly Zuromski, PhD  ·  617-475-0595  ·  kzuromski@franciscanchildrens.org

Always discuss trial participation with your own doctor first.

Locations (1)

Franciscan Hospital For Children, Inc.Brighton, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05796531